Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Albany Molecular Research Inc raises FY 2014 earnings guidance


Tuesday, 6 May 2014 08:00am EDT 

Albany Molecular Research Inc:Increases FY 2014 adjusted EPS guidance to $0.78-$0.84 to reflect addition of Cedarburg Pharmaceuticals and strengthening contract business.Expects FY 2014 adjusted EBITDA between $54 mln and $60 mln.FY 2014 EPS of $0.79 and EBITDA of $59 mln - Thomson Reuters I/B/E/S. 

Company Quote

19.65
0.08 +0.41%
22 Aug 2014